ANDA 70795, held by Teva Pharmaceutical Industries. Amiloride Hydrochloride; Hydrochlorothiazide.
As of Nov 22, 2026, ANDA 70795 (Amiloride Hydrochloride and Hydrochlorothiazide), held by Teva Pharmaceutical Industries, was first approved by FDA on Jul 15, 1987, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 15, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amiloride Hydrochloride and HydrochlorothiazideEQ 5MG ANHYDROUS;50MG · tablet;oral | Amiloride Hydrochloride; Hydrochlorothiazide | Discontinued |
| Feb 16, 1995 | Supplement 16Manufacturing | Approved | None posted |
| Sep 6, 1994 | Supplement 15Manufacturing | Approved | None posted |
| Jun 17, 1994 | Supplement 14Manufacturing | Approved | None posted |
| May 12, 1994 | Supplement 13Manufacturing | Approved | None posted |
| May 24, 1993 | Supplement 11Labeling | Approved | None posted |
| May 24, 1993 | Supplement 12Manufacturing | Approved | None posted |
| May 4, 1993 | Supplement 10Manufacturing | Approved | None posted |
| Oct 23, 1992 | Supplement 9Labeling | Approved | None posted |
| Jun 9, 1992 | Supplement 8Labeling | Approved | None posted |
| May 7, 1992 | Supplement 7Labeling | Approved | None posted |
| Aug 31, 1988 | Supplement 6Manufacturing | Approved | None posted |
| Apr 28, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Mar 8, 1988 | Supplement 5Manufacturing | Approved | None posted |
| Mar 4, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Mar 4, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Mar 4, 1988 | Supplement 4Labeling | Approved | None posted |
| Jul 15, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters